Diabetes drug trial unethical and dangerous, researcher charges

'Dr. David Juurlink, chief of clinical pharmacology and toxicology at Sunnybrook Health Sciences Center in Toronto, was the lead author of a 2009 study that found that compared to elderly diabetics taking a drug called pioglitazone (marketed as Actos), those taking Avandia were about 30% more likely to suffer heart failure or death. On Tuesday, Juurlink joined with Dr. Sidney Wolfe, director of health research for the consumer watchdog group Public Citizen, in calling a further clinical trial pitting the two diabetes drugs against each other "unethical" and "dangerous."'


Read more...

• About
• Twitter
• Facebook
• Google+

Unknown

Iam Raju Al Nima From healtheverydays
Find out health informations update, beauty care,fitness energizing moves, easy recipes, expert tips, and advice on losing weight from healtheverydays

Likes

Dislikes

Share

?

@healthhotnews

new Health articles

Raju Al Nima

Posted by Unknown Posted on 04.14 with No comments